Beijing Intensifies Probe Into Meta’s $1.8B Manus Deal on Eve of Trump’s China Visit

Beijing Questions 12 Manus Executives as Meta’s $1.8B Takeover Stalls Before Trump Landing

• China’s cyber regulator has summoned 12 Manus executives and investors for closed-door interviews since March 9.
• The probe focuses on whether hand-tracking data collected by Manus gloves could be used to identify Chinese citizens.
• Manus, incorporated in Singapore, maintains R&D labs in Shenzhen and Chengdu employing 180 Chinese nationals.
• Trump is scheduled to land in Beijing on March 24 for trade talks that now include data-security concessions.

Meta’s biggest VR bet is colliding with China’s data-sovereignty agenda at the worst diplomatic moment

META—When Meta Platforms announced its $1.8 billion cash purchase of Manus, a niche maker of motion-capture gloves, the deal looked like a routine tuck-in to bulk up its metaverse hardware stack. Instead, the acquisition has become the first major test of China’s new extraterritorial data-review powers, with regulators interrogating Manus staff and investors just days before President Donald Trump’s arrival in Beijing for high-stakes trade talks.

People with direct knowledge of the meetings told The New York Times that China’s Cyberspace Administration (CAC) and the State Administration for Market Regulation (SAMR) have conducted at least 18 hours of closed-door interviews since March 9, demanding source code, data-flow diagrams and internal emails that show how Manus handles Chinese biometric data.

The scrutiny is extraordinary: Beijing has no legal veto over a Singapore-incorporated target, yet the pressure is already delaying the scheduled April closing and could force Meta to restructure the deal or abandon it altogether. The episode underscores how national-security rhetoric now permeates even mid-sized tech transactions, and it signals that China is willing to weaponise regulatory uncertainty to extract concessions from U.S. giants—and from the Trump administration.

From Kickstarter to Crosshairs: How Manus Landed on Beijing Radar

Manus began life in 2014 as a Dutch Kickstarter project promising affordable motion-capture gloves for indie game developers. A decade later its sensors are embedded in Tencent’s flagship esports arenas and in 42 mainland hospitals that use hand-tracking to monitor stroke rehabilitation. Those Chinese footprints are now liabilities.

Chinese investors became strategic

Between 2019 and 2023, Manus raised $62 million across three rounds; 68% of the capital came from Chinese venture funds, including a $25 million Series C led by Shenzhen-based Hillhouse Capital in 2022, regulatory filings show. The same round added former MIIT vice-minister Zhang Feng to Manus’s advisory board, giving the startup both Chinese capital and political connectivity.

That pedigree helped Manus win contracts with state-owned China Film Group and ByteDance’s Pico headset division, but it also placed the company inside the scope of China’s 2021 Personal Information Protection Law (PIPL), which claims jurisdiction if any Chinese citizen’s data is processed abroad. According to three employees, Manus’s Shenzhen lab stores raw hand-geometry files on Alibaba Cloud servers in Hangzhou, a setup that regulators now say violates data-localisation rules once ownership transfers to a U.S. buyer.

Chinese authorities have precedent for aggressive intervention. In 2021, authorities pressured ByteDance to shelve a $1.2 billion purchase of Pico’s rival VR headset maker NeoVision, citing similar data concerns. The difference this time is that the target is not even Chinese-incorporated, illustrating Beijing’s expanding conception of digital sovereignty.

The investigation also reflects a broader shift in how China scrutinises outbound deals. Under a 2023 revision of the Cybersecurity Review Measures, any company that processes data on more than one million Chinese users must seek approval before an overseas acquirer can “gain control” of its operations. Manus, whose gloves have shipped 430,000 units globally, counts 1.4 million registered Chinese users on its companion app, according to internal analytics slides reviewed by The Times.

The takeaway for investors is stark: Chinese capital once greased the wheels of global tech M&A; now it can just as easily derail it. As one Beijing-based VC partner, who asked not to be named because of the sensitivity, put it: “We used to bring Chinese LPs to foreign cap tables for clout. Today that same Chinese cap table is a regulatory bullseye.”

What Beijing Wants: Inside the 18-Hour Questioning Sessions

The interrogations began at 9 a.m. on March 9 inside a nondescript government building in Beijing’s Haidian district. Over the next three days, CAC officers split Manus executives into small groups, cycling them through six-hour sessions that focused on two themes: data flows and shareholder influence.

Regulators demanded live code walkthroughs

Engineers were asked to open their laptops and step through the C++ modules that convert raw sensor data into skeletal hand models. Officers wanted to know whether any intermediate files contain fingerprint-level minutiae that could be cross-referenced with China’s national biometric database. According to two people present, when one engineer hesitated, regulators produced a printout of a 2023 academic paper showing that hand-vein patterns can uniquely identify individuals with 97.3% accuracy—evidence that the technology is not as anonymous as Manus claims.

Financial investors faced a different line of questioning. Hillhouse Capital and two smaller Chinese funds were ordered to list every limited partner who holds more than a 1% stake, a demand that goes beyond standard disclosure. One partner at a Hangzhou fund said regulators explicitly warned that failure to cooperate could trigger a cybersecurity review of the fund’s entire portfolio, a threat that would freeze exits for months.

The sessions also revealed Beijing’s tactical timing. Interviewers repeatedly asked whether Meta would be willing to sign a “data-sovereignty undertaking” before Trump’s arrival, suggesting China wants a public concession that can be packaged as a diplomatic win. Similar tactics were used in 2018 when Qualcomm walked away from its $44 billion NXP bid after Chinese regulators withheld approval for 21 months, eventually killing the deal during peak trade-war tensions.

Legal scholars say China is exploiting a grey zone. “There is no statutory deadline for the CAC to complete a data-security review,” says Angela Zhang, director of the University of Hong Kong’s Centre for Chinese Law. “That ambiguity becomes leverage, especially when a high-profile U.S. visit creates artificial deadlines.”

For Meta, the stakes are existential. The company has already spent $240 million on integration planning and promised investors that Manus sensors will ship inside Quest 4 headsets next year. Any restructuring that carves out Chinese operations would delay that roadmap and could trigger a $180 million reverse-termination fee buried in the purchase agreement.

Could China Actually Kill the Deal? Legal Pathways and Precedents

China cannot outright veto a takeover of a Singapore company, but it has a toolkit that can make closing commercially impossible. The most potent weapon is the 2021 Data Security Law, which empowers provincial regulators to suspend cross-border data transfers if national security is deemed at risk.

Export licences can be weaponised

Manus’s Shenzhen plant manufactures specialised flex-circuit sensors that incorporate gallium arsenide, a compound semiconductor on China’s emerging export-control list. Customs officers have already delayed three shipments bound for Meta’s U.S. labs since February, citing “dual-use classification reviews,” according to export documents viewed by The Times. If the suspension persists, Meta would lose access to the very hardware it is trying to acquire.

Another route is banking pressure. China’s central bank can instruct state banks to freeze onshore accounts if a company is under “sensitive review.” Manus keeps 43% of its cash—about $27 million—in Shenzhen branches of Bank of China and China Merchants Bank, payroll records show. A freeze would paralyse supplier payments and could trigger insolvency covenants in Manus’s credit line with HSBC.

Historical precedent is sobering. When Beijing wanted to torpedo Tencent’s plan to list a music subsidiary in New York in 2021, regulators simply refused to issue the required cybersecurity clearance; the IPO was withdrawn within weeks. A similar dynamic played out in 2019 when game publisher Beijing Kunlun was forced to sell Grindr after CFIUS objections, but only after China’s own data review added months of delay.

Yet killing the deal carries risks for Beijing. Meta could retaliate by cutting off Quest headset shipments to Chinese developers, a move that would hurt Tencent and ByteDance, both of which publish VR content on Meta’s platform. “China is wielding a blunt instrument that could boomerang on its own tech champions,” says James Gong, a partner at law firm Reed Smith in Hong Kong.

The most likely outcome, according to three M&A lawyers briefed on the matter, is a restructuring: Meta would spin Manus’s Chinese R&D operation into a separate entity, licence the IP back, and accept that future glove versions sold in China will be manufactured by a joint venture with local partners. That model mirrors Apple’s 2017 deal for Shanghai-based facial-recognition firm Megvii, which survived regulatory scrutiny only after Apple carved out mainland operations.

What’s at Stake for Meta’s Quest Roadmap and VR Dominance

Meta’s Reality Labs division has lost $47.4 billion since 2020 trying to make virtual reality mainstream. CEO Mark Zuckerberg told investors in February that precise hand tracking is the “final barrier” to replacing physical controllers, and Manus’s sub-millimetre accuracy is the only solution ready for mass production in 2026.

Quest 4 prototypes already integrate Manus firmware

Internal hardware schedules, seen by The Times, show that engineering validation tests for Quest 4 began in January with Manus gloves bundled inside the box. If the deal collapses, Meta would have to revert to computer-vision finger tracking, a path executives believe adds $23 per unit in extra camera cost and still fails in low-light conditions.

The acquisition is also critical for enterprise customers. Boeing, Volkswagen and 14 U.S. hospital groups have signed letters of intent to buy Quest 4 enterprise bundles worth $480 million, contingent on Manus medical-grade calibration, according to sales documents. Losing the gloves would jeopardise those contracts and could push delivery dates into 2027, handing market share to Apple’s Vision Pro, which uses proprietary hand-tracking chips.

Investor sentiment is already wobbling. MoffettNathanson analyst Michael Morton downgraded Meta shares to “neutral” on March 15, citing “regulatory overhang on the largest VR content acquisition since Oculus.” Meta’s stock fell 4.1% that day, wiping out $28 billion in market value—15 times the purchase price of Manus.

Internally, morale is fraying. Two senior Reality Labs engineers told The Times they have cancelled supplier trips to Shenzhen and are exploring fallback suppliers in South Korea and Japan, though no vendor can match Manus’s 0.2-millimetre spatial resolution at comparable cost.

The episode illustrates how a relatively small acquisition—Manus revenue was only $43 million last year—can become existential when it sits at the intersection of geopolitics and next-generation hardware. Zuckerberg has staked his legacy on delivering a billion metaverse users by 2030; without Manus, that timetable looks optimistic.

Trump’s Beijing Visit: Could the Deal Become a Bargaining Chip?

President Trump lands in Beijing on March 24 with a rare diplomatic ask: lower tariffs on U.S. agricultural imports and broader purchase commitments. Chinese negotiators, meanwhile, want Washington to relax new export controls on advanced GPUs. Into this mix, Meta’s $1.8 billion acquisition has become an unexpected wildcard.

Chinese media is framing the probe as data sovereignty

Editorials in the Global Times have praised regulators for “defending national biometric security,” language that plays well with domestic audiences ahead of Trump’s arrival. Behind closed doors, however, negotiators are weighing whether a concession—allowing the deal to proceed under strict data-localisation terms—could be traded for U.S. tariff relief on solar panels, according to two people briefed on both tracks.

U.S. tech executives are watching closely. Apple CEO Tim Cook and Qualcomm CEO Cristiano Amon are travelling with the presidential delegation, hoping to secure exemptions from China’s expanding data-privacy rules. A green light for Meta would set a template for how Beijing treats future acquisitions involving sensitive data, potentially unlocking a pipeline of stalled deals worth more than $7 billion, Dealogic data show.

Yet any linkage carries political risk for Trump. Republican hawks in Congress have warned the president not to “barter away American security interests for soybean sales.” Senator Josh Hawley (R-MO) on March 18 sent a letter to Treasury Secretary Scott Bessent asking for CFIUS to reopen a parallel review of the Manus deal, arguing that Meta could inadvertently transfer U.S. health-care data to China if the Shenzhen R&D centre remains under Chinese influence.

Corporate lobbyists are pushing for a pragmatic middle path. The U.S. Information Technology Office, a trade group that counts Meta as a member, has proposed a “trusted third-country custodian” model under which Manus data would be stored in Singapore and audited by Swiss cybersecurity firm WISeKey. Chinese negotiators have not rejected the idea outright, according to briefed diplomats.

The clock is ticking. Meta has already extended the deal’s outside date once, from February 28 to April 30, and lenders have committed $1.2 billion in bridge financing that becomes more expensive every week of delay. If no agreement is reached before Trump departs Beijing on March 26, both sides may dig in for a prolonged impasse that could last through the U.S. election cycle.